Lv3
330 积分 2024-08-14 加入
A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia
8天前
已完结
Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia
8天前
已完结
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD: A multicenter phase 2 study
8天前
已完结
Rituximab Plus Bortezomib for Relapsed and Refractory Warm Autoimmune Hemolytic Anemia: A Prospective Phase 2 Trial
8天前
已完结
Chinese expert consensus on hematologic malignancy karyotyping
8天前
已完结
Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring
8天前
已完结
Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia
8天前
已完结
Identification and treatment of myeloma cast nephropathy with crystalline light chain proximal tubulopathy induced by Vλ2 light chain
8天前
已完结
Non-crystalline light chain proximal tubulopathy associated with monoclonal gammopathy of renal significance: A case report and review of the literature
8天前
已完结
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD: A multicenter phase 2 study
8天前
已完结
皖公网安备34019202002308
